Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Experts red-flag cancer drug price cuts as patented therapies see zero relief, markups exceed benchmark

Experts said there should be comprehensive, cost-based price controls covering all oncology therapies, permanent statutory margin caps across distribution channels and full scrutiny of company assistance programmes.

Experts red-flag cancer drug price cuts as patented therapies see zero relief, markups exceed benchmark

We haven't written up this one. Live Mint has the full story — the link below goes straight to it.

Read the original at livemint.com →

More in Health & Medicine

More from Thursday 29 October →